398 related articles for article (PubMed ID: 17249857)
41. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective.
Nicholl D; Akhras KS; Diels J; Schadrack J
Curr Med Res Opin; 2010 Apr; 26(4):943-55. PubMed ID: 20163295
[TBL] [Abstract][Full Text] [Related]
42. Health services utilization and cost of retinitis pigmentosa.
Frick KD; Roebuck MC; Feldstein JI; McCarty CA; Grover LL
Arch Ophthalmol; 2012 May; 130(5):629-34. PubMed ID: 22652848
[TBL] [Abstract][Full Text] [Related]
43. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
[TBL] [Abstract][Full Text] [Related]
44. Burden of Herpes Zoster Among Patients with Psoriasis in the United States.
Singer D; Thompson-Leduc P; Ma S; Gupta D; Cheng WY; Sendhil SR; Sundar M; Hagopian E; Stempniewicz N; Duh MS; Poston S
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2649-2668. PubMed ID: 37740149
[TBL] [Abstract][Full Text] [Related]
45. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States.
Patel MS; Gebremariam A; Davis MM
Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1157-63. PubMed ID: 18999945
[TBL] [Abstract][Full Text] [Related]
46. Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States.
Soliman AM; Surrey E; Bonafede M; Nelson JK; Castelli-Haley J
Adv Ther; 2018 Mar; 35(3):408-423. PubMed ID: 29450864
[TBL] [Abstract][Full Text] [Related]
47. Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma.
Song X; Liu Z; Cappell K; Gregory C; Said Q; Prestifilippo J; Charles H; Hulbert J; Bissler J
J Med Econ; 2017 Apr; 20(4):388-394. PubMed ID: 27998195
[TBL] [Abstract][Full Text] [Related]
48. Herpes zoster-attributable resource utilization and cost burden in patients with solid organ transplant.
Palmer L; White RR; Johnson BH; Fowler R; Acosta CJ
Transplantation; 2014 Jun; 97(11):1178-84. PubMed ID: 24892964
[TBL] [Abstract][Full Text] [Related]
49. Healthcare use and costs associated with post-traumatic stress syndrome in a community sample of older adults: results from the ESA-Services study.
Lamoureux-Lamarche C; Vasiliadis HM; Préville M; Berbiche D
Int Psychogeriatr; 2016 Jun; 28(6):903-11. PubMed ID: 26598143
[TBL] [Abstract][Full Text] [Related]
50. Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States.
Li Q; Chen SY; Burstin SJ; Levin MJ; Suaya JA
Open Forum Infect Dis; 2016 Apr; 3(2):ofw067. PubMed ID: 27419151
[TBL] [Abstract][Full Text] [Related]
51. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
52. Disease burden of herpes zoster in Korea.
Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
J Clin Virol; 2010 Apr; 47(4):325-9. PubMed ID: 20181512
[TBL] [Abstract][Full Text] [Related]
53. Healthcare resource use and costs associated with chronic kidney disease in US private insurance patients with multiple myeloma.
Bhowmik D; Song X; Intorcia M; Kent ST; Shi N
J Oncol Pharm Pract; 2019 Jun; 25(4):855-864. PubMed ID: 29661050
[TBL] [Abstract][Full Text] [Related]
54. Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model.
Grant DM; Mauskopf JA; Bell L; Austin R
Pharmacotherapy; 1997; 17(2):333-41. PubMed ID: 9085325
[TBL] [Abstract][Full Text] [Related]
55. Economic burden of paediatric-onset disabilities among young and middle-aged adults in the USA: a cohort study of privately insured beneficiaries.
Whitney D; Kamdar N; Hirth RA; Hurvitz EA; Peterson MD
BMJ Open; 2019 Sep; 9(9):e030490. PubMed ID: 31481565
[TBL] [Abstract][Full Text] [Related]
56. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.
Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
Appl Health Econ Health Policy; 2013 Aug; 11(4):407-13. PubMed ID: 23700254
[TBL] [Abstract][Full Text] [Related]
57. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
[TBL] [Abstract][Full Text] [Related]
58. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
59. The incidence of herpes zoster in a United States administrative database.
Insinga RP; Itzler RF; Pellissier JM; Saddier P; Nikas AA
J Gen Intern Med; 2005 Aug; 20(8):748-53. PubMed ID: 16050886
[TBL] [Abstract][Full Text] [Related]
60. Healthcare costs and resource utilization in patients with severe aplastic anemia in the US.
Cai B; Said Q; Li X; Li FY; Arcona S
J Med Econ; 2019 Oct; 22(10):1055-1062. PubMed ID: 31296074
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
